Get the App

Back Stocks profile

Stock analysis tool for investors

Aarti Drugs Ltd.

₹485.60 -2.10 (-0.43%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

485.00

Today’s High

498.40

52W low

313.90

52W High

645.80

Open Price

490.30

Prev. Close

519.40

Volume

160003.00

Value

77697456.80

Fundamentals

Market Cap Cr

4464.40

Price to Earnings

24.80

Price to Book Value

3.70

Dividend Yield

0.20

PE to Growth

-6.70

Op Revenue TTM Cr

2709.02

Net Profit TTM Cr

180.21

Cash From Operating Activity Cr

134.20

Return on Equity %

13.94

EMA & SMA

Bullish Moving Averages

7

Bearish Moving Averages

9

5Day EMA Rs

486.9

10Day EMA Rs

484.4

12Day EMA Rs

483.8

20Day EMA Rs

484.5

26Day EMA Rs

487.1

50Day EMA Rs

499.9

100Day EMA Rs

505.5

200Day EMA Rs

493

5Day SMA Rs

488.8

10Day SMA Rs

482.2

20Day SMA Rs

479.4

30Day SMA Rs

480.1

50Day SMA Rs

502.4

100Day SMA Rs

533.9

150Day SMA Rs

507.8

200Day SMA Rs

474.5

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

01 Dec, 2023

43

Week

35.9

Month

33.5

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

489.67

PIVOT

First Resistance

494.33

Second Resistance

503.07

Third Resistance

507.73

First Support

480.93

Second Support

476.27

Third Support

467.53

Relative Strength Index

48.84

Money Flow Index

50.58

MACD

-3.27

MACD Signal

-7.01

Average True Range

15.22

Average Directional Index

17.71

Rate of Change (21)

5.46

Rate of Change (125)

6.81

Commodity Channel Index

93.9

Williams %R

-47.5

BETA

1 Month

-0.01

3 Month

0.8

1 Year

0.39

3 Year

0.21

PRICE CHANGE ANALYSIS

↑ 1.06%

1 Week

Low

High

483

500.9

↑ 5.46%

1 Month

Low

High

458

500.9

↓ -14.75%

3 Months

Low

High

444

625

↑ 6.81%

6 Months

Low

High

440.55

645.75

↑ 8.14%

1 Year

Low

High

313.9

645.75

Indicator Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021 Graph
Total Qtr Revenue cr 578.28 592.29 697.34 626.50 624.92 551.44 642.10 594.83 511.59 507.43 452.93
Operating Expenses Qtr Cr 512.12 519.73 607.89 556.55 554.65 496.47 557.38 502.53 441.56 431.52 373.69
Operating Profit Qtr Cr 65.42 71.90 88.52 68.98 70.18 54.73 84.10 90.68 69.14 74.27 78.39
EBIDT Qtr Cr 66.16 72.56 89.45 69.95 70.27 54.97 84.72 92.30 70.03 75.91 79.24
Depreciation Qtr Cr 11.78 11.75 11.68 11.87 11.92 11.83 11.88 11.95 11.81 11.76 11.66
Net Profit Qtr Cr 34.58 39.54 53.17 36.71 36.58 26.35 53.00 55.85 40.61 45.54 50.24
Basic EPS Qtr Rs 3.75 4.27 5.74 3.96 3.95 2.85 5.72 6.03 4.39 4.90 5.39
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual Cr 2500.20 2255.95 1921.31 1635.98 1456.77
Operating Expenses Annual Cr 2215.57 1932.99 1513.62 1390.51 1254.96
Operating Profit Annual in Cr 282.40 318.18 401.27 244.41 199.30
Operating Profit Margin Annual % 11.30 14.10 20.89 14.94 13.68
Total Expenses Annual Cr 2295.39 2000.45 1583.83 1469.39 1332.91
EBIDT Annual Cr 284.64 322.96 407.69 245.47 201.81
EBIDT Annual margin % 11.38 14.32 21.22 15.00 13.85
Depreciation Cr 47.29 47.39 47.60 46.67 40.39
PAT Before ExtraOrdinary Items Annual Cr 152.81 195.00 257.71 135.67 87.26
Net Profit Annual Cr 152.81 195.00 257.71 135.67 87.26
Basic EPS Annual Rs 16.50 21.04 27.65 58.12 37.42
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual Cr 1114.30 972.17 859.61 621.79 518.58
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 250.20 207.67 255.50 292.91 307.00
Total Current Liabilities Annual Cr 830.99 854.68 521.89 555.99 547.36
Total Capital Plus Liabilities Annual Cr 2195.50 2034.52 1637.01 1470.70 1372.93
Fixed Assets Annual Cr 795.23 709.03 646.47 622.53 618.04
Total Non Current Assets Annual Cr 845.96 761.33 676.88 645.33 637.93
Total Current Assets Annual Cr 1349.53 1273.19 960.13 825.36 735.00
Total Assets Annual Cr 2195.50 2034.52 1637.01 1470.70 1372.93
Contingent Liabilities plus Commitments Annual Cr 258.17 194.24 152.85 89.82 74.68
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual Cr 162.28 39.90 154.08 196.15 147.30
Cash from Investing Activity Annual Cr -131.14 -125.36 -68.93 -29.35 -59.33
Cash from Financing Annual Activity Cr -30.54 84.11 -85.28 -167.76 -86.96
Net Cash Flow Annual Cr 0.61 -1.35 -0.13 -0.96 1.01
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual Rs 120.33 104.99 92.23 266.86 219.90
ROE Annual % 13.71 20.05 29.98 21.82 16.82
ROCE Annual % 17.39 23.35 32.29 21.73 19.55
Total Debt to Total Equity Annual 0.48 0.53 0.34 0.53 0.85
EBDIT Annual Margin % 11.39 14.34 21.29 15.01 13.87
Indicator Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021 Graph
Total Qtr Revenue cr 642.23 661.71 743.28 664.97 687.77 622.22 697.23 641.46 579.70 581.57 502.72
Operating Expenses Qtr Cr 565.10 577.03 648.87 593.31 613.45 554.82 608.27 544.80 505.88 500.26 420.82
Operating Profit Qtr Cr 76.44 84.08 93.54 70.65 74.27 67.14 86.00 90.00 73.74 79.69 80.93
EBIDT Qtr Cr 77.13 84.68 94.41 71.66 74.32 67.40 88.96 96.66 73.82 81.31 81.90
Depreciation Qtr Cr 12.61 12.60 12.50 12.62 12.66 12.54 12.55 12.60 12.48 12.42 12.28
Net Profit Qtr Cr 39.59 47.85 56.09 36.68 38.75 34.79 55.32 58.28 42.58 48.81 51.65
Basic EPS Qtr Rs 4.29 5.18 6.07 3.96 4.18 3.76 5.97 6.29 4.60 5.25 5.54
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual Cr 2718.25 2499.96 2159.30 1807.57 1563.35
Operating Expenses Annual Cr 2410.45 2159.21 1717.67 1544.27 1353.57
Operating Profit Annual in Cr 305.61 329.44 437.10 261.82 207.37
Operating Profit Margin Annual % 11.24 13.18 20.24 14.48 13.26
Total Expenses Annual Cr 2494.07 2230.01 1790.52 1626.75 1436.09
EBIDT Annual Cr 307.80 340.75 441.63 263.30 209.78
EBIDT Annual margin % 11.32 13.63 20.45 14.57 13.42
Depreciation Cr 50.32 50.05 49.88 48.75 42.56
PAT Before ExtraOrdinary Items Annual Cr 166.36 205.00 280.40 141.40 89.75
Net Profit Annual Cr 166.31 205.04 280.41 141.40 89.75
Basic EPS Annual Rs 17.97 22.12 30.09 60.57 38.48
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual Cr 1192.43 1036.36 913.42 652.49 543.45
Minority Interest Liability Annual Cr 0.23 -0.06 -0.02 -0.00 0.00
Total Non Current Liabilities Annual Cr 295.75 231.60 257.25 299.31 321.06
Total Current Liabilities Annual Cr 932.98 940.06 595.36 624.70 590.98
Total Capital Plus Liabilities Annual Cr 2421.40 2207.96 1766.01 1576.50 1455.49
Fixed Assets Annual Cr 886.58 766.67 684.66 656.02 657.61
Total Non Current Assets Annual Cr 929.05 814.59 709.22 672.50 671.20
Total Current Assets Annual Cr 1492.35 1393.37 1056.80 904.00 784.29
Total Assets Annual Cr 2421.40 2207.96 1766.01 1576.50 1455.49
Contingent Liabilities plus Commitments Annual Cr 262.94 211.49 155.67 92.06 77.41
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual Cr 134.20 69.64 154.85 250.74 143.09
Cash from Investing Activity Annual Cr -163.97 -148.86 -71.68 -33.21 -61.67
Cash from Financing Annual Activity Cr 16.54 92.03 -81.13 -215.41 -80.07
Net Cash Flow Annual Cr -13.23 12.80 2.04 2.13 1.35
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual Rs 128.80 111.91 98.00 280.04 230.45
ROE Annual % 13.94 19.78 30.69 21.67 16.51
ROCE Annual % 17.29 22.92 33.46 22.54 19.34
Total Debt to Total Equity Annual 0.51 0.52 0.33 0.52 0.87
EBDIT Annual Margin % 11.33 13.69 20.49 14.57 13.43
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Prakash Moreshwar Patil 9.24 10702347 0 0
Seema Harshit Savla 4.93 10702348 0 0
Harshit Manilal Savla 4.74 10702349 0 0
Rashesh Chandrakant Gogri 4.65 10702350 0 0
Priti Prakash Patil 4.4 10702351 0 0
Hetal Gogri Gala 3.06 10702352 0 0
Chandrakant Vallabhaji Gogri 1.87 10702353 0 0
Mirik Rajendra Gogri 1.79 10702354 0 0
Jaya Chandrakant Gogri 1.71 10702355 0 0
Renil Rajendra Gogri 1.54 10702356 0 0
Adhish P. Patil 1.24 10702357 0 0
Vishwa Harshit Savla 1.03 10702358 0 0
Aashay Rashesh Gogri 0.96 10702359 0 0
Rajendra Vallabhaji Gogri 0.56 10702360 0 0
Gogri Finserv Pvt. Ltd. 3.8 10702378 0 0
Anushakti Enterprise Private Limited 2.62 10702379 0 0
Alchemie Finserv Pvt. Ltd. 2.21 10702380 0 0
Aashyav Business Trust (Alabhya Trusteeship Private Limited) 1.5 10702381 0 0
Safechem Enterprises Private Limited 1.22 10702382 0 0
Tulip Family Trust (Gloire Trusteeship Services Private Limited) 1.01 10702383 0 0
Orchid Family Trust (Relacion Trusteeship Services Private Limited) 0.99 10702384 0 0
Paridhi Business Trust (Saswat Trusteeship Private Limited) 0.64 10702385 0 0
Dilesh Roadlines Pvt Ltd 0.54 10702386 0 0
Name Holding Percent Holding Id
Dsp Small Cap Fund 4.64 10702392
Name Holding Percent Holding Id
Nikhil Parimal Desai 1.15 10702407
HUF 0.73 10702399
Harit Pragji Shah 2.67 10702411
Jayshree Harit Shah 1.79 10702412
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Feb 08, 2023 1 INTERIM Feb 08, 2023 Equity Share
Feb 09, 2022 1 INTERIM Feb 10, 2022 Equity Share
Nov 03, 2020 2.5 INTERIM Nov 04, 2020 Equity Share
Feb 17, 2020 2 INTERIM Feb 18, 2020 Equity Share
Jul 26, 2019 1 FINAL - Equity Share
Aug 01, 2018 1 FINAL - Equity Share
Aug 09, 2017 1 FINAL - Equity Share
Mar 22, 2016 3 INTERIM Mar 24, 2016 Equity Share
Feb 12, 2016 1.5 INTERIM Feb 15, 2016 Equity Share
Nov 10, 2015 2.25 INTERIM Nov 14, 2015 Equity Share
Aug 05, 2015 3 FINAL - Equity Share
Feb 04, 2015 5 INTERIM Feb 05, 2015 Equity Share
Nov 19, 2014 5 INTERIM Nov 20, 2014 Equity Share
Jul 02, 2014 5.5 FINAL - Equity Share
Feb 05, 2014 4.5 INTERIM Feb 06, 2014 Equity Share
Nov 19, 2013 3 INTERIM Nov 20, 2013 Equity Share
Jul 24, 2013 4 FINAL - Equity Share
Feb 11, 2013 3 INTERIM Feb 12, 2013 Equity Share
Nov 05, 2012 3 INTERIM Nov 06, 2012 Equity Share
Aug 17, 2012 3 FINAL - Equity Share
Feb 06, 2012 2 INTERIM Feb 07, 2012 Equity Share
Jul 14, 2011 2.5 FINAL - Equity Share
Feb 07, 2011 2.5 INTERIM Feb 08, 2011 Equity Share
Aug 18, 2010 5 FINAL - Equity Share
Jul 23, 2009 3 FINAL - Equity Share
Aug 13, 2008 1.8 FINAL - Equity Share
Mar 20, 2007 1.2 INTERIM Mar 21, 2007 Equity Share
Jul 19, 2006 1.5 FINAL - Equity Share
Jul 27, 2005 1.6 FINAL - Equity Share
Nov 04, 2004 1.4 INTERIM Nov 06, 2004 Equity Share
Jun 25, 2004 1.8 FINAL - Equity Share
Nov 13, 2003 1.2 INTERIM Nov 15, 2003 Equity Share
Jul 25, 2003 1.5 FINAL - Equity Share
Jun 20, 2002 - FINAL - Equity Share
Oct 23, 2001 - INTERIM Nov 08, 2001 Equity Share
Jun 11, 2001 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Oct 19, 2023 Quarterly Results -
Jul 21, 2023 Quarterly Results & Buy Back -
Apr 29, 2023 Audited Results -
Jan 27, 2023 Quarterly Results & Interim Dividend -
Oct 20, 2022 Quarterly Results -
Jul 27, 2022 Quarterly Results -
May 09, 2022 Audited Results -
Jan 31, 2022 Audited Results & Interim Dividend -
Oct 27, 2021 Quarterly Results -
Jul 27, 2021 Quarterly Results -
May 15, 2021 Audited Results -
Mar 19, 2021 Buy Back of Shares -
Jan 25, 2021 Quarterly Results -
Oct 23, 2020 Audited Results -
Oct 20, 2020 Audited Results & Interim Dividend -
Aug 20, 2020 Bonus issue -
Jul 25, 2020 Quarterly Results -
May 15, 2020 Audited Results -
Feb 06, 2020 Quarterly Results & Interim Dividend -
Oct 23, 2019 Audited Results -
Jul 26, 2019 Quarterly Results -
May 15, 2019 Audited Results & Final Dividend -
Mar 15, 2019 Buy Back of Shares -
Feb 11, 2019 Quarterly Results -
Nov 02, 2018 Quarterly Results -
Aug 13, 2018 Quarterly Results -
May 16, 2018 Audited Results & Final Dividend -
Feb 13, 2018 Quarterly Results -
Jan 08, 2018 Buy Back of Shares -
Nov 13, 2017 Quarterly Results -
Aug 18, 2017 Quarterly Results -
May 23, 2017 Audited Results & Final Dividend -
Feb 08, 2017 Quarterly Results -
Nov 09, 2016 Quarterly Results -
Oct 17, 2016 Buy Back of Shares -
Aug 12, 2016 Quarterly Results -
May 05, 2016 Audited Results -
Mar 16, 2016 3rd Interim Dividend -
Feb 05, 2016 Quarterly Results & 2nd Interim Dividend -
Nov 06, 2015 Quarterly Results & Interim Dividend -
Jul 31, 2015 Quarterly Results -
May 20, 2015 Audited Results & Final Dividend -
Mar 26, 2015 Others To consider & approve the allotment of 121,08,550 Equity shares as Bonus issue in the proportion of 1 new equity share for every 1 (One) existing fully paid equity shares.
Jan 30, 2015 Quarterly Results & Interim Dividend Second Interim Dividend
Nov 14, 2014 Quarterly Results & Interim Dividend -
Aug 08, 2014 Quarterly Results -
Apr 30, 2014 Audited Results & Final Dividend -
Jan 31, 2014 Quarterly Results & 2nd Interim Dividend -
Nov 14, 2013 Quarterly Results & Interim Dividend -
Aug 02, 2013 Quarterly Results -
May 16, 2013 Audited Results & Final Dividend -
Feb 06, 2013 Quarterly Results & Interim Dividend -
Oct 31, 2012 Quarterly Results & Interim Dividend -
Aug 10, 2012 Quarterly Results -
Jul 09, 2012 Audited Results Inter alia, to reconsider, approve and take on record the Audited Financial Results for the year ended March 31, 2012, post amalgamation of Suyash Laboratories Ltd. with the Company.
May 25, 2012 Audited Results & Final Dividend -
Feb 09, 2012 Others The Board has consider the Sucession Plan post retirement of Shri. Chandrakant V Gogri as the Chairman of the Company w.e.f August 16, 2012 on his attaining the age of 66 years.
Feb 01, 2012 Quarterly Results & Interim Dividend -
Nov 11, 2011 Quarterly Results -
Jul 29, 2011 Quarterly Results -
May 25, 2011 Audited Results & Final Dividend -
Feb 02, 2011 Quarterly Results & Interim Dividend -
Oct 29, 2010 Quarterly Results -
Jul 30, 2010 Quarterly Results -
May 26, 2010 Audited Results & Dividend -
Jan 25, 2010 Quarterly Results -
Dec 20, 2009 Allotment of Equity Shares The Board has allotted 4,00,000 Equity Shares of Rs. 10/- each fully paid up against exercise of option of Conversion by the holders of Conv. Warrants issued by the Company on preferential basis.
Oct 30, 2009 Quarterly Results -
Jul 30, 2009 Quarterly Results -
May 20, 2009 Audited Results & Dividend -
Jan 29, 2009 Quarterly Results (Revised)
Oct 20, 2008 Quarterly Results -
Aug 06, 2008 To call an EGM & Others To consider: Allotment of one Equity share of Rs 10/- each & to determine "Relevant Date" for the purpose said issue price for the Preferential Issue of the warrants.
Jul 28, 2008 Quarterly Results -
May 13, 2008 Audited Results & Final Dividend -
Jan 28, 2008 Quarterly Results -
Oct 30, 2007 Quarterly Results -
Jul 30, 2007 Quarterly Results -
May 18, 2007 Audited Results & Final Dividend Has not recommended any final dividend.
Mar 12, 2007 Interim Dividend -
Jan 22, 2007 Quarterly Results -
Oct 19, 2006 Quarterly Results -
Jul 31, 2006 Quarterly Results -
May 10, 2006 Accounts & Dividend -
Jan 27, 2006 Quarterly Results -
Nov 08, 2005 Quarterly Results & Half Yearly Results -
Jul 29, 2005 Quarterly Results & Accounts (Revised)
May 05, 2005 Others Board has decided to acquire controlling stake in Suyash Laboratories Ltd (Suyash) thereby making it 51% subsidiary of the Company subject to necessary approvals from appropriate authority.
Apr 25, 2005 Accounts, Qtr Results & F. Dividend -
Apr 08, 2005 Allotment of Unsecured FCCB's Board has allotted 12750 Unsecured Foreign Currency Convertible Bonds (FCCBs) of US$ 1000 each aggregating to US$ 12,750,000 (US Dollar Twelve Million Seven Hundred Fifty Thousand Only).
Jan 21, 2005 Quarterly Results -
Dec 31, 2004 To issue securities like FCCB's Proposal to issue/offer securities like Foreign Currency Convertible Bonds (FCCB) and/or Equity Shares (through Depository Receipt Mechanism) and/or Fully Convertible Debentures.
Oct 29, 2004 Quarterly Results -
Jul 28, 2004 Accounts -
Apr 23, 2004 Accounts & Final Dividend -
Jan 21, 2004 Quarterly Results -
Oct 31, 2003 Interim Dividend & Quarterly Results (Revised)
Jul 21, 2003 Quarterly Results -
Apr 23, 2003 Final Dividend & Accounts -
Jan 20, 2003 Quarterly Results -
Oct 28, 2002 Accounts & Buy Back of Shares -
Jul 19, 2002 Quarterly Results -
May 10, 2002 Final Dividend -
Apr 17, 2002 Dividend & Quarterly Results -
Mar 09, 2002 Interim Dividend (Cancelled)
Jan 18, 2002 Quarterly Results -
Oct 31, 2001 Interim Dividend & Half Yearly Results -
Jul 18, 2001 Quarterly Results -
Apr 18, 2001 Accounts & Dividend Dividend announced on 11/04/2001
Jan 22, 2001 Quarterly Results -
Oct 18, 2000 Quarterly Results -
Apr 18, 2000 Accounts -
Mar 28, 2000 2nd Interim Dividend -
Jan 28, 2000 Quarterly Results -
Oct 27, 1999 Quarterly Results -
Jul 30, 1999 Quarterly Results -
Apr 29, 1999 Quarterly Results -
Jan 29, 1999 Quarterly Results -
Jan 22, 1999 Revised -
Jan 20, 1999 Quarterly Results -
Oct 30, 1998 Quarterly Results -
Jul 20, 1998 Quaterly Results -
May 05, 1998 Accounts & Dividend -
Nov 26, 1997 Half Yearly Results -
Ex-Date Bonus Ratio Record Date
Sep 30, 2020 3:1 2020-10-01
Mar 24, 2015 1:1 2015-03-25
Bigul
29 Nov 2023

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Issue of Duplicate share certificate
28 Nov 2023

Aarti Drugs listed as top pick of the week' by Axis Securities 4 key reasons

 The brokerage has a buy' recommendation on the stock with a target price of 528, indicating an upside of 10 percent from its current market price of 480.30.
Bigul
24 Nov 2023

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of loss of share certificate
Bigul
22 Nov 2023

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Cancellation of Schedule of Analyst/ Institutional Investor meetings
Bigul
21 Nov 2023

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of issue of duplicate share certificate
Bigul
16 Nov 2023

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of share certificate
Bigul
16 Nov 2023

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Analyst meet
Bigul
04 Nov 2023

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of loss of share certificate
Bigul
02 Nov 2023

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Analyst Meet
Bigul
27 Oct 2023

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Transcript of earning call for Q2 & H1 FY24
See all News

FAQs

The latest market price of Aarti Drugs Ltd. on NSE was Rs. 485.60 as of today.

The opening share price of Aarti Drugs Ltd. was Rs. 490.30 as of today.

The 52-week high share price of Aarti Drugs Ltd. was Rs. 645.80.

The 52 week low share price of Aarti Drugs Ltd. was Rs. 313.90.

Aarti Drugs Ltd. has a market cap of Rs. 4464.40 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Aarti Drugs Ltd. is -6.70. Please refer to the Fundamentals section for further details.

The operating revenue for Aarti Drugs Ltd. in the last FY was Rs.  2709.02 crore. Please refer to the Financials section for further details.

The Net Profit for Aarti Drugs Ltd. in the last FY was Rs. 180.21 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Aarti Drugs Ltd. was on 2023-02-08 for Rs. 1 per share. According to today’s share price, the dividend yield of Aarti Drugs Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Aarti Drugs Ltd. was as of 2020-09-30. The bonus ratio declared in this issue was 3:1. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Aarti Drugs Ltd..